PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Abimmune Biopharma, Inc., San Diego, CA, USA.\', \'Department of Biochemistry and Molecular Biology, Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/22221751.2021.2023330
?:hasPublicationType
?:journal
  • Emerging microbes & infections
is ?:pmid of
?:pmid
?:pmid
  • 34951568
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Omicron: a drug developer\'s perspective.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all